For example, TMEM92 is a pivotal biomarker of immune resistance in pancreatic cancer, and its elevated expression is associated with poor prognosis and suboptimal immunotherapy outcomes [58]. The gene discussed is TMEM92; the disease is familial pancreatic carcinoma.